Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-491-3 | CAS number: 15471-17-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 47.02 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 37.5
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1 763.2 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- A systemic NOAEL of 1000 mg/kg bw /day from the Combined Repeated Dose Toxicity Study with the Reproduction/ Developmental Toxicity Screening Test (OECD 422) (Dunster, 2013) was converted into the corrected inhalatory NOAEC taking into account the standard daily respiratory volume of 0.38 m³ for rats, the standard respiratory volume in workers during 8 hours: 6.7 m³ under normal conditions and 10 m³ by light activity as well as the absorption rates (oral 100 %, inhalation 100 % (worst-case)).
- AF for dose response relationship:
- 1
- Justification:
- default (three doses were tested using a spacing range of 2-4 fold)
- AF for differences in duration of exposure:
- 3
- Justification:
- the default assessment factor was adjusted taking into account study duration of 56 days (see Discussion)
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scaling should be applied in case of oral-to-inhalation extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- default; no substance and route specific information on toxicokinetic and toxicodynamic is available for animals and humans
- AF for intraspecies differences:
- 5
- Justification:
- default for workers
- AF for the quality of the whole database:
- 1
- Justification:
- default (GLP guideline study)
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties are identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 13.33 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 150
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 2 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- A systemic NOAEL of 1000 mg/kg bw /day from the Combined Repeated Dose Toxicity Study with the Reproduction/ Developmental Toxicity Screening Test (OECD 422) (Dunster, 2013) was converted into the corrected dermal NOAEL taking into account the rates for absorpion (oral 100 %, dermal 50 %).Thereby the corrected dermal NOAEL is: oral NOAEL x (ABS oral-rat/ABS dermal-rat) x (ABS dermal-rat/ABS dermal-human) = 2000 mg/kg bw.
- AF for dose response relationship:
- 1
- Justification:
- default (three doses were tested using a spacing range of 2-4 fold)
- AF for differences in duration of exposure:
- 3
- Justification:
- the default assessment factor was adjusted taking into account study duration of 56 days (see Discussion)
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- default for rats in case of oral-to-dermal extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- default; no substance and route specific information on toxicokinetic and toxicodynamic is available for animals and humans
- AF for intraspecies differences:
- 5
- Justification:
- default for workers
- AF for the quality of the whole database:
- 1
- Justification:
- default (GLP guideline study)
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties are identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
The calculation of the DNELs is performed in accordance with the principles given in ECHA (2012) “Guidance on Information Requirements and Chemical Safety Assessment, Chapter R.8: Characterisation of dose [concentration]-response for human health”.
Available dose descriptors:
The target substance 1-(3-sulphonatopropyl)pyridinium is not acutely toxic by oral and dermal routes of exposure (oral LD50 is > 5000 mg/kg bw, Ullmann and Sacher, 1983; dermal LD50 > 2000 mg/kg bw, Driscoll, 2001). Inhalation is not a relevant route of exposure due to the low vapour pressure of the substance (4.24E-5 Pa at 25 °C, EPIWIN). The target substance is non-volatile and therefore no risk of irritation or sensitisation of respiratory tract exists. The substance is not irritating to skin and eyes and not sensitising to skin (Clauss and Ullmann, 1982; Ullmann and Suter, 1982; Driscoll, 2001). Therefore, no DNELs for acute/short-term exposures (systemic and local effects) and for long-term exposures (local effects for both inhalation and dermal routes) need to be derived.
For the long-term exposure – systemic effects (inhalation and dermal DNEL), the NOAEL of 1000 mg/kg bw established in the Combined Repeated Dose Toxicity Study with the Reproduction/ Developmental Toxicity Screening Test (OECD 422, Dunster, 2013) was used as the starting point. This is the lowest NOAEL known for the target substance after repeated exposures to rats. The DNELs for inhalation and dermal routes can be derived by route-to-route extrapolation applying appropriate assessment factors.
For the other non-threshold endpoints (mutagenicity, eye and skin irritation/corrosion) no DNELs can be derived because a No-Observed-Effect-Level could not be established from the relevant studies.
Modification of the starting point:
Considering all available data on the target substance it becomes clear that these substances exert their effects by a threshold mode of action. Thus, DNELs can be calculated for the threshold endpoints based on the most relevant dose descriptors per endpoint. DNELs are derived based on the available toxicity data for the target substance and reflecting the routes, the duration and the frequency of exposure. DNELs are derived only for workers. No DNELs are needed for general population since there are no consumer uses for the target substance.
Bioavailability (absorption):
There is no substance-specific experimental information on absorption by the oral, dermal and inhalation routes available. The absorption rates are assessed based on the physico-chemical properties and on the effects observed in treated animals in the available studies.
Oral absorption:
Based on the molecular weight of 201.24 g/mol, negative logPow (< -2.78) value and high water solubility (240.5 g/L, EPIWIN) the target substance is expected to be well absorbed via gastrointestinal tract. The substance will be readily dissolved into the gastrointestinal fluids and may pass through aqueous pores or be carried through the epithelial barrier by the bulk passage of water. However, the available toxicity data point to a low toxicity potential by oral route. No mortality was observed in animals administered test substance at 5000 mg/kg bw. At necropsy, mottled lungs were detected in three animals, the fact indicating systemic absorption. No toxicologically significant effects were observed in animals treated up to 1000 mg/kg bw during 8 weeks in the Combined Repeated Dose Toxicity Study with the Reproduction/ Developmental Toxicity Screening Test (OECD 422, Dunster, 2013). Based on this data, absorption by oral route is considered to be significant (for the detailed information on absorption please refer to section "Toxicokinetics, metabolism and distribution" of this CSR or section 7.1 of IULID file).The oral absorption is therefore set to 100 % (worst-case) for the purposes of hazard assessment (DNEL derivation). The oral absorption is considered to be the same in animals and in humans (worst-case).
Dermal absorption:
No significant dermal absorption is expected for the target substance. The negative logPow value (< -2.78) is out of the range of the optimal logPow values favourable for dermal absorption (-1 to 4). Furthermore, the substance has very high water solubility (204.5 g/L, EPIWIN). Therefore, the substance may be to hydrophilic to cross lipid rich environment of the stratum corneum. The molecular weight of 201.24 g/mol (< 500 g/mol) points to a moderate absorption through the skin.The substance is not irritating to skin and therefore no enhancement of dermal absorption is expected due to irritating properties. The systemic toxicity via the skin is low. This has been shown by the results of the acute dermal toxicity study, in which no mortality occurred after dermal application of 2000 mg/kg bw in rats. Based on these data, 50 % dermal absorption is considered appropriate. Dermal absorption in rats, rabbits and in humans is assumed to be the same since no information for dermal absorption of the target substance in humans is available.
Inhalation absorption
Absorption by inhalation is considered to be negligible due to the low vapour pressure (4.24E-5 Pa at 25 °C, EPIWIN) of the target substance. However, a certain amount of the substance can be available for inhalation due to its appearance form as powder and its high water solubility (204.5 g/L, EPIWIN). The average particle size is 32.101 µm (< 100 µm), indicating the potential to be inspired. According to the Endpoint specific guidance R.7.C., particles with aerodynamic diameters below 50 µm may reach thoracic region of lungs. Moreover, water soluble dusts could readily diffuse/dissolve into the mucus lining the respiratory tract and thereafter be absorbed through aqueous pores due to its high solubility in water. Based on this data, 100 % absorption is assumed for inhalation route (in case of the route-to-route extrapolation) and considered to be equal in rats and in humans since no substance specific information is available.
Route-to-route extrapolation:
Oral-to-inhalation extrapolation is performed to obtain long-term inhalation NOAEC for systemic effects. The following formula was used:
Corrected inhalatory NOAEC = oral NOAEL x (1/sRVrat) x (ABSoral-rat/ABSinh-human) x (6.7 m³/10 m³) where sRV is the standard respiratory volume of rats during 8 hours (= 0.38 m³/kg/day); ABS-absorption and 6.7 m³ and 10 m³ are standard respiratory volumes for workers under normal conditions and by light activity.
Oral-to-dermal extrapolation is performed to obtain dermal NOAEL for systemic effects. The following formula was used (as described in the Example B.5 of the Appendix R.8 -2, ECHA REACH Guidance R.8):
Corrected dermal NOAEL = oral NOAEL x (ABSoral-rat/ABSderm-rat) x (ABSderm-rat/ABSderm-human) = oral NOAEL x (ABSoral-rat/ABSderm-human).
Exposure conditions:
No modification of the starting points for exposure conditions was necessary since the systemic dose after oral administration of the test material was already assessed in respiratory volume taken for rats during 8 h (0.38 m³).
Differences in the respiratory volumes between experimental animals and humans were used when an oral rat NOAEL from the oral one-generation reproductive toxicity study in rats was used to assess inhalation exposure in humans. 0.38 m³/kg/day is the standard respiratory volumes in rats during 8h exposure. 6.7 and 10 m³ are standard respiratory volumes for workers under normal conditions and by light activity, respectively.
Applying of assessment factors and calculation of DNELs:
The assessment factors have been applied to the corrected starting point to obtain the endpoint specific DNELs. Assessment factors (AFs) correct uncertainties and variability within and between species in the effect data.
Interspecies differences:
The species-specific default assessment factor of 4 for allometric scaling for rats was applied in the case of employment of the Combined Repeated Dose Toxicity Study with the Reproduction/ Developmental Toxicity Screening Test (OECD 422) which was used to derive the dermal long-term DNEL.
No allometric scaling factor was applied when the oral NOAEL was used for the derivation of inhalation long-term DNEL.
An assessment factor of 2.5 was applied for remaining interspecies differences in toxicodynamics between rat and human in all cases.
Intraspecies differences:
An assessment factor of 5 was applied for workers for all endpoints and for all exposure routes.
Extrapolation of duration:
An assessment factor of 3 was applied for duration of exposure. The exposure duration in the present screening study was up to 8 weeks.According to the ECETOC technical report No.86 “Derivation of Assessment Factors for Human Health Risk Assessment”, “…study duration of six months provides essentially the same value for the NOAEL as would be found after chronic exposure. Using the conservative assumption of linear accumulation of effects with time, extrapolation from one to six months would require a factor of 6 and since the NOAEL would not change between six month and two years, this should theoretically be the maximum factor necessary. Thus an extrapolation of study duration from 1 to 6 months would suggest a default assessment factor of 6, assuming linear bioaccumulation of the substance or assuming linear accumulation of tissue damage during the six-month’ exposure. This default factor should be the same for extrapolation from one month to chronic exposure. Consequently, a default factor of 2 would be assumed to be appropriate when extrapolating from studies of three to six months.” Further, “…compounds, such as most industrial chemicals, that have relatively short half-lives, are not reactive to tissue components and do not deplete essential elements, might have NOAEL in 28-day studies close to those for chronic studies”. The target substance is relatively harmless; it is of low acute toxicity, not irritating, not sensitising and did not produce toxicologically relevant systemic effects in the Combined Repeated Dose Toxicity Study with the Reproduction/ Developmental Toxicity Screening Test (OECD 422). The exposure duration of 8 weeks corresponds to approximately 2 months. Considering the principle of “linearity of bioaccumulation and damaging effects” outlined in the guidance, an appropriate assessment factor for exposure duration of 56 days would be 3 (6 months/2 months (= 56 days)).
Quality of whole data base:
A default assessment factor of 1 was used.
Issues related to dose response:
A default assessment factor of 1 was applied when the NOAEL from the Combined Repeated Dose Toxicity Study with the Reproduction/ Developmental Toxicity Screening Test (OECD 422) (the dose spacing was chosen properly).
Calculation of DNELs:
Long-term exposure – systemic effects (inhalation DNEL):
The oral rat NOAEL of 1000 mg/kg bw was converted into the inhalation NOAEC:
Inhalation NOAEC = oral NOAEL x (1/sRVrat) x (ABSoral-rat/ABSinhal-human) x (6.7 m³/10 m³) = 1000 mg/kg bw x (1/0.38 m³/kg/day) x (100 %/100 %) x (6.7/10) = 1763.2 mg/m³
DNEL = 1763.2 mg/m³/(2.5 x 5 x 3 x 1 x 1) = 47.02 mg/m³.
Assessment factors are: 2.5 – remaining interspecies differences, 5 – intraspecies, 3 – study duration (screening study of 56 days), 1 – dose response, 1 – quality of data base. The total AF amounts to 37.5.
Long-term exposure – systemic effects (dermal DNEL):
For the oral rat NOAEL of 500 mg/kg bw the following conversion was necessary:
Dermal NOAEL =oral NOAEL x (ABSoral-rat/ABSderm-human) = 1000 x (100 %/50 %) = 2000 mg/kg bw
DNEL = 2000 mg/kg bw/(4 x 2.5 x 5 x 3 x 1 x 1) = 13.33 mg/kg bw.
Assessment factors are: 4 – interspecies, 2.5 – remaining interspecies differences, 5 – intraspecies, 3 – study duration (screening study of 56 days), 1 – dose response, 1 – quality of data base. The total AF amounts to 150.
Selected DNELs
DNEL systemic inhalation = 47.02 mg/m³
DNEL systemic dermal (long-term) = 13.33 mg/kg bw
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 11.59 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 869.57 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Due to the low vapour pressure of the test substance an exposure hazard via inhalation is not very likely for humans and hence, repeated dose toxicity testing via the inhalation route was not done. The oral route was chosen as it is better suited to assess overall systemic effects. Therefore a route-to-route extrapolation from an oral repeated dose study, as a worst case, is justified.
A systemic NOAEL of 1000 mg/kg bw /day from the Combined Repeated Dose Toxicity Study with the Reproduction/ Developmental Toxicity Screening Test (OECD 422) (Dunster, 2013) was converted into the corrected inhalatory NOAEC by using the default respiratory volume for rats (8 h), assuming 100% absorption by oral route and 100% absorption by inhalation route, as set out in detail in subchapter „Toxicokinetics“.
- AF for dose response relationship:
- 1
- Justification:
- default (three doses were tested using a spacing range of 2-4 fold)
- AF for differences in duration of exposure:
- 3
- Justification:
- the default assessment factor was adjusted taking into account study duration of 56 days (see Discussion)
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No allometric scaling should be applied in case of oral-to-inhalation extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- default; no substance and route specific information on toxicokinetic and toxicodynamic is available for animals and humans
- AF for intraspecies differences:
- 10
- Justification:
- default for general population
- AF for the quality of the whole database:
- 1
- Justification:
- default (GLP guideline study)
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties are identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 6.67 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 2 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
A systemic NOAEL of 1000 mg/kg bw /day from the Combined Repeated Dose Toxicity Study with the Reproduction/ Developmental Toxicity Screening Test (OECD 422) (Dunster, 2013) was converted into the corrected dermal NOAEL taking into account the rates for absorpion (oral 100 %, dermal 50 %).Thereby the corrected dermal NOAEL is: oral NOAEL x (ABS oral-rat/ABS dermal-rat) x (ABS dermal-rat/ABS dermal-human) = 2000 mg/kg bw.
- AF for dose response relationship:
- 1
- Justification:
- default (three doses were tested using a spacing range of 2-4 fold)
- AF for differences in duration of exposure:
- 3
- Justification:
- the default assessment factor was adjusted taking into account study duration of 56 days (see Discussion)
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- default for rats in case of oral-to-dermal extrapolation
- AF for other interspecies differences:
- 2.5
- Justification:
- default; no substance and route specific information on toxicokinetic and toxicodynamic is available for animals and humans
- AF for intraspecies differences:
- 10
- Justification:
- default for general population
- AF for the quality of the whole database:
- 1
- Justification:
- default (GLP guideline study)
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties are identified.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.33 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- other: no modification required
- Explanation for the modification of the dose descriptor starting point:
NOAEL was derived from oral study, no modification required.
- AF for dose response relationship:
- 1
- Justification:
- default (three doses were tested using a spacing range of 2-4 fold)
- AF for differences in duration of exposure:
- 3
- Justification:
- the default assessment factor was adjusted taking into account study duration of 56 days (see Discussion)
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- default factor for allometric scaling (rat to human) as given in ECHA guidance R.8
- AF for other interspecies differences:
- 2.5
- Justification:
- default; no substance and route specific information on toxicokinetic and toxicodynamic is available for animals and humans
- AF for intraspecies differences:
- 10
- Justification:
- default for general population
- AF for the quality of the whole database:
- 1
- Justification:
- default (GLP guideline study)
- AF for remaining uncertainties:
- 1
- Justification:
- No remaining uncertainties are identified.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
The principles of the DNEL calculation for the general population are the same as already described for workers. However, there are additional considerations or deviations for:
Modification of the starting point:
Bioavailability (absorption)
The oral absorption in rats and in humans is assumed to be the same since no information for oral absorption for target chemical in rats and in humans is available.
Respiratory volumes:
No differences in the respiratory volumes under normal conditions and by light activity in humans were taken into account. A default respiratory volume of 1.15 m³/kg bw for rats was used to convert oral NOAEL into inhalation NOAEC.
Applying of assessment factors:
A higher assessment factor of 10 (instead of 5 for workers) for intraspecies variation/differences of human population was used.
Calculation of endpoint-specific DNEL for general population
Long-term exposure - systemic effects (oral)
The oral NOAEL of 50 mg/kg bw was not modified for differences in absorption by oral route since no substance- and route specific information is available: Oral NOAEL rat = oral NOAEL human = 1000 mg/kg bw.
DNEL = 1000 mg/kg bw/(1 x 3 x 4 x 2.5 x 10 x 1 x 1) = 3.33 mg/kg bw.
Assessment factors are:1 – dose response (clear dose response), 3 – study duration (screening study of 56 days), 4 – interspecies, allometric scaling, 2.5 – remaining interspecies differences, 10 – intraspecies (general population), 1 – quality of data base, 1 – remaining uncertainties (none remaining).
Long-term exposure - systemic effects (dermal)
The oral NOAEL of 1000 mg/kg bw was converted into the dermal NOAEL: Dermal NOAEL = oral NOAEL x (ABS oral-rat/ABS dermal-human) = 1000 mg/kg bw x (100%/50%) = 2000 mg/kg bw.
DNEL = 2000 mg/kg bw/(1 x 3 x 4 x 2.5 x 10 x 1 x 1) = 6.67 mg/kg bw.
Assessment factors are: 1 – dose response (clear dose response), 3 – study (screening study of 56 days), 4 – interspecies, allometric scaling, 2.5 – remaining interspecies differences, 10 – intraspecies (general population), 1 – quality of data base, 1 – remaining uncertainties (none remaining).
Long-term exposure - systemic effects (inhalation)
The oral NOAEL of 1000 mg/kg bw was converted into the inhalation NOAEC:
Corrected inhalation NOAEC = oral rat NOAEL x (1/1.15 m³/kg bw/day) x (ABS oral-rat/ABS inhal-human), where 1.15 m³/kg bw is standard respiratory volume of rats during 24 h, ABS is absorption (values are the same as described for workers).
Corrected Inhalation NOAEC = 1000 mg/kg bw x (1/1.15 m³/kg/day) x (100%/100%) = 869.57 mg/m³
DNEL = 869.57 mg/m³/(1 x 3 x 1 x 2.5 x 10 x 1 x 1) = 11.59 mg/m³.
Assessment factors are:1 – dose response (clear dose response), 3 – study duration (screening study of 56 days), 1 – interspecies, no allometric scaling required for oral to inhalation exposure, 2.5 – remaining interspecies differences, 10 – intraspecies (general population), 1 – quality of data base, 1 – remaining uncertainties (none remaining).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.